Cargando…

Intra-articular Injection of Mesenchymal Stem Cells After High Tibial Osteotomy in Osteoarthritic Knee: Two-Year Follow-up of Randomized Control Trial

Intra-articular injection of adipose-derived mesenchymal stem cell (ADMSC) after medial open-wedge high tibial osteotomy (MOWHTO) would be a promising disease-modifying treatment by correcting biomechanical and biochemical environment for arthritic knee with varus malalignment. However, there is a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jun-Ho, Kim, Kang-Il, Yoon, Wan Keun, Song, Sang-Jun, Jin, Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216209/
https://www.ncbi.nlm.nih.gov/pubmed/35674255
http://dx.doi.org/10.1093/stcltm/szac023
_version_ 1784731376825663488
author Kim, Jun-Ho
Kim, Kang-Il
Yoon, Wan Keun
Song, Sang-Jun
Jin, Wook
author_facet Kim, Jun-Ho
Kim, Kang-Il
Yoon, Wan Keun
Song, Sang-Jun
Jin, Wook
author_sort Kim, Jun-Ho
collection PubMed
description Intra-articular injection of adipose-derived mesenchymal stem cell (ADMSC) after medial open-wedge high tibial osteotomy (MOWHTO) would be a promising disease-modifying treatment by correcting biomechanical and biochemical environment for arthritic knee with varus malalignment. However, there is a paucity of clinical evidence of the treatment. This randomized controlled trial (RCT) was aimed to assess regeneration of cartilage defect, functional improvement, and safety of intra-articular injection of ADMSCs after MOWHTO compared with MOWHTO alone for osteoarthritic knee with varus malalignment. This RCT allocated 26 patients into the MOWHTO with ADMSC-injection group (n = 13) and control (MOWHTO-alone) group (n = 13). The primary outcome was the serial changes of cartilage defect on periodic magnetic resonance imaging (MRI) evaluation using valid measurements until postoperative 24 months. Secondary outcomes were the 2-stage arthroscopic evaluation for macroscopic cartilage status and the postoperative functional improvements of patient-reported outcome measures until the latest follow-up. Furthermore, safety profiles after the treatment were evaluated. Cartilage regeneration on serial MRIs showed significantly better in the ADMSC group than in the control group. The arthroscopic assessment revealed that total cartilage regeneration was significantly better in the ADMSC group. Although it was not significant, functional improvements after the treatment showed a tendency to be greater in the ADMSC group than in the control group from 18 months after the treatment. No treatment-related adverse events, serious adverse events, and postoperative complications occurred in all cases. Concomitant intra-articular injection of ADMSCs with MOWHTO had advantages over MOWHTO alone in terms of cartilage regeneration with safety at 2-year follow-up, suggesting potential disease-modifying treatment for knee OA with varus malalignment.
format Online
Article
Text
id pubmed-9216209
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-92162092022-06-23 Intra-articular Injection of Mesenchymal Stem Cells After High Tibial Osteotomy in Osteoarthritic Knee: Two-Year Follow-up of Randomized Control Trial Kim, Jun-Ho Kim, Kang-Il Yoon, Wan Keun Song, Sang-Jun Jin, Wook Stem Cells Transl Med Human Clinical Articles Intra-articular injection of adipose-derived mesenchymal stem cell (ADMSC) after medial open-wedge high tibial osteotomy (MOWHTO) would be a promising disease-modifying treatment by correcting biomechanical and biochemical environment for arthritic knee with varus malalignment. However, there is a paucity of clinical evidence of the treatment. This randomized controlled trial (RCT) was aimed to assess regeneration of cartilage defect, functional improvement, and safety of intra-articular injection of ADMSCs after MOWHTO compared with MOWHTO alone for osteoarthritic knee with varus malalignment. This RCT allocated 26 patients into the MOWHTO with ADMSC-injection group (n = 13) and control (MOWHTO-alone) group (n = 13). The primary outcome was the serial changes of cartilage defect on periodic magnetic resonance imaging (MRI) evaluation using valid measurements until postoperative 24 months. Secondary outcomes were the 2-stage arthroscopic evaluation for macroscopic cartilage status and the postoperative functional improvements of patient-reported outcome measures until the latest follow-up. Furthermore, safety profiles after the treatment were evaluated. Cartilage regeneration on serial MRIs showed significantly better in the ADMSC group than in the control group. The arthroscopic assessment revealed that total cartilage regeneration was significantly better in the ADMSC group. Although it was not significant, functional improvements after the treatment showed a tendency to be greater in the ADMSC group than in the control group from 18 months after the treatment. No treatment-related adverse events, serious adverse events, and postoperative complications occurred in all cases. Concomitant intra-articular injection of ADMSCs with MOWHTO had advantages over MOWHTO alone in terms of cartilage regeneration with safety at 2-year follow-up, suggesting potential disease-modifying treatment for knee OA with varus malalignment. Oxford University Press 2022-06-08 /pmc/articles/PMC9216209/ /pubmed/35674255 http://dx.doi.org/10.1093/stcltm/szac023 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Human Clinical Articles
Kim, Jun-Ho
Kim, Kang-Il
Yoon, Wan Keun
Song, Sang-Jun
Jin, Wook
Intra-articular Injection of Mesenchymal Stem Cells After High Tibial Osteotomy in Osteoarthritic Knee: Two-Year Follow-up of Randomized Control Trial
title Intra-articular Injection of Mesenchymal Stem Cells After High Tibial Osteotomy in Osteoarthritic Knee: Two-Year Follow-up of Randomized Control Trial
title_full Intra-articular Injection of Mesenchymal Stem Cells After High Tibial Osteotomy in Osteoarthritic Knee: Two-Year Follow-up of Randomized Control Trial
title_fullStr Intra-articular Injection of Mesenchymal Stem Cells After High Tibial Osteotomy in Osteoarthritic Knee: Two-Year Follow-up of Randomized Control Trial
title_full_unstemmed Intra-articular Injection of Mesenchymal Stem Cells After High Tibial Osteotomy in Osteoarthritic Knee: Two-Year Follow-up of Randomized Control Trial
title_short Intra-articular Injection of Mesenchymal Stem Cells After High Tibial Osteotomy in Osteoarthritic Knee: Two-Year Follow-up of Randomized Control Trial
title_sort intra-articular injection of mesenchymal stem cells after high tibial osteotomy in osteoarthritic knee: two-year follow-up of randomized control trial
topic Human Clinical Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216209/
https://www.ncbi.nlm.nih.gov/pubmed/35674255
http://dx.doi.org/10.1093/stcltm/szac023
work_keys_str_mv AT kimjunho intraarticularinjectionofmesenchymalstemcellsafterhightibialosteotomyinosteoarthritickneetwoyearfollowupofrandomizedcontroltrial
AT kimkangil intraarticularinjectionofmesenchymalstemcellsafterhightibialosteotomyinosteoarthritickneetwoyearfollowupofrandomizedcontroltrial
AT yoonwankeun intraarticularinjectionofmesenchymalstemcellsafterhightibialosteotomyinosteoarthritickneetwoyearfollowupofrandomizedcontroltrial
AT songsangjun intraarticularinjectionofmesenchymalstemcellsafterhightibialosteotomyinosteoarthritickneetwoyearfollowupofrandomizedcontroltrial
AT jinwook intraarticularinjectionofmesenchymalstemcellsafterhightibialosteotomyinosteoarthritickneetwoyearfollowupofrandomizedcontroltrial